This paper is only available as a PDF. To read, Please Download here.
Abstract
Background
This article describes the qualitative methods used to develop the EXAcerbation of Chronic Pulmonary Disease Tool (EXACT), a new patient-reported outcome (PRO) instrument for evaluating frequency, severity, and duration of exacerbations of chronic obstructive pulmonary disease (COPD).
Methods
Focus groups and interviews were conducted in the United States with COPD patients treated for exacerbations during the past 6 months. Participants were asked to describe exacerbation attributes, care-seeking cues, and indications of progression and recovery. An iterative process was used to identify themes in the data to inform instrument content and structure. Cognitive debriefing interviews were performed to evaluate and revise the draft item pool. Experts in COPD, instrument development, and clinical research participated in the process.
Results
Eighty-three subjects participated in elicitation focus groups or interviews (n = 48); elicitation interviews with cognitive debriefing (n = 23), or cognitive interviews alone (n = 12). Mean age of the sample was 65 years (SD = 10); 45% were male; mean FEV-1% predicted was 44% (SD = 16). Participants characterized exacerbations as a persistent increase in the severity of respiratory symptoms and other systemic manifestations accompanied by a dramatic reduction in activity. Specific attributes included shortness of breath, chest congestion, cough, sputum, chest discomfort, feeling weak or tired, sleep disturbances, and concern or worry. The diary card of 23 candidate items was debriefed in booklet and electronic format.
Conclusions
Qualitative data from patients and input from experts formed the basis of the EXACT's structure and item pool, ready for empirically based item reduction and reliability and validity testing.
Keywords
References
- Global strategy for the diagnosis, management and prevention of COPD.Available from: http://www.goldcopd.org([Accessed August 1, 2009].)Date: 2007
- Chronic obstructive pulmonary disease: symptoms and signs.Eur Respir Mon. 2006; 38: 7-23
- COPD as a lung disease with systemic consequences—clinical impact, mechanisms, and potential for early intervention.COPD. 2008; 5: 235-256
- COPD exacerbations: definitions and classifications.Eur Respir J. 2003; 41: 46s-53s
- Toward a consensus definition for COPD exacerbations.Chest. 2000; 117: 398S-401S
- Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes.Int J Chron Obstruct Pulmon Dis. 2009; 4: 245-251
- The epidemiology and economics of chronic obstructive pulmonary disease.Proc Am Thorac Soc. 2007; 4: 502-506
- Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 1998; 157: 1418-1422
- Exacerbation rate, health status and mortality in COPD—a review of potential interventions.Int J Chron Obstruct Pulmon Dis. 2009; 4: 203-223
- Reported and unreported exacerbations of COPD: analysis by diary cards.Chest. 2008; 133: 34-41
- Optimizing economic outcomes in the management of COPD.Int J Chron Obstruct Pulmon Dis. 2008; 3: 1-10
- A 4-year trial of tiotropium in chronic obstructive pulmonary disease.N Engl J Med. 2008; 359: 1543-1554
- The TORCH (towards a revolution in COPD health) survival study protocol.Eur Respir J. 2004; 24: 206-210
- Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.Chest. 2004; 125: 953-964
- Exacerbations of chronic obstructive pulmonary disease.Eur Respir J. 2007; 29: 1224-1238
- Outcomes for COPD pharmacological trials: from lung function to biomarkers.Eur Respir J. 2008; 31: 416-469
- Definition and severity of COPD exacerbations.in: Wedzicha W Martinez F Exacerbations of Chronic Obstructive Pulmonary Disease (COPD). Informa Healthcare, New York2009
- Relationship between respiratory symptoms and medical treatment in exacerbations of COPD.Eur Respir J. 2005; 26: 406-413
- Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort.Am J Respir Crit Care Med. 2008; 177: 396-401
- Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003; 48 (discussion 1213-1205.): 1204-1213
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.Eur Respir J. 2004; 23: 932-946
- Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2000; 161: 1608-1613
- Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis.Thorax. 2001; 56: 947-953
- Draft guidance for industry on acute bacterial exacerbations of chronic bronchitis in patients with chronic obstructive pulmonary disease: developing antimicrobial drugs for treatment; availability.Fed Regist. 2008; 73 ([Accessed December, 2006].): 49684-49685
- Psychometric Theory. 3rd ed. McGraw Hill, New York1994
- Use of existing PRO instruments and their modification: good research practices for evaluating and documenting content validity.Value Health. 2009; 12: 1075-1083
- Qualitative Inquiry and Research Design: Choosing Among Five Traditions. Sage Publications, Thousand Oaks, CA1997
- Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment.Pharmacoeconomics. 2008; 26: 363-370
- Designing Qualitative Research. 2nd ed. Sage, Newbury Park1995
- Exacerbations of chronic obstructive pulmonary disease—a patients' perspective.Prim Care Respir J. 2006; 15: 102-109
- Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study.Chest. 2006; 130: 133-142
- The patient's burden: physical and psychological effects of acute exacerbations of chronic bronchitis.J Antimicrob Chemother. 2000; 45: 25-32
- Choose your method: a comparison of phenomenology, discourse analysis, and grounded theory.Qual Health Res. 2007; 17: 1372-1380
- Symbolic Interactionism. University of California Press, Berkeley, CA1986
- Grounding Grounded Theory: Guidelines for Qualitative Inquiry. Academic Press, San Diego, CA1999
- Introduction to Phenomenology. Cambridge University Press, Cambridge2000
- Exploring Phenomenology: A Guide to the Field and Its Literature. American Library Association, Chicago1974
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.Thorax, CA. 1999; 54: 581-586
- The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.Br Med J. 1959; 2: 257-266
- A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.Am Rev Respir Dis. 1992; 145: 1321-1327
- The experience of rheumatoid arthritis pain and fatigue: examining momentary reports and correlates over one week.Arthritis Care Res. 1997; 10: 185-193
- The accuracy of pain and fatigue items across different reporting periods.Pain. 2008; 139: 146-157
- Despite technical problems personal digital assistants outperform pen and paper when collecting patient diary data.J Clin Epidemiol. 2007; 60: 8-17
- The use of electronic diaries in respiratory studies.Drug Inf J. 1997; 31: 759-764
- A randomized trial of electronic versus paper pain diaries in children: impact on compliance, accuracy, and acceptability.Pain. 2004; 107: 213-219
- Proving the eDiary dividend.Appl Clin Trials. 2004; 13: 54-68
- Compliance with momentary pain measurement using electronic diaries: a systematic review.Eur J Pain. 2009; 13: 354-365
- Patient non-compliance with paper diaries.BMJ. 2002; 324: 1193-1194
- Electronic diaries and questionnaires: designing user interfaces that are easy for all patients to use.Qual Life Res. 2004; 13: 1199-1207
Article info
Identification
Copyright
© 2010 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
User license
Elsevier user license | How you can reuse 
Elsevier's open access license policy
Elsevier user license
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy
